Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Andrew Winokur, PhD, MD
JCP
Original Research
Esketamine Nasal Spray and Adverse Events Over Time
September 19, 2022
This study looked at the occurrence and severity of adverse events over time with esketamine nasal spray in MDD patients also receiving an oral antidepressant.
David J. Williamson
,
Jagadish P. Gogate
,
Jennifer K. Kern Sliwa
, et al
JCP
Original Research
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
December 15, 2012
George I. Papakostas
,
Ottavio V. Vitolo
,
Waguih W. IsHak
, et al
JCP
Original Research
Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia
October 15, 2003
Andrew Winokur
,
Nicholas A. DeMartinis III
,
Daniel P. McNally
, et al
JCP
Academic Highlights
The Pharmacologic Rationale for the Clinical Use of Antidepressants
November 15, 1997
Trond Aarre
,
Otto Benkert
,
Jonathan R. T. Davidson
, et al
JCP
Original Research
A Comparison of Nefazodone and Fluoxetine on Mood and on Objective, Subjective, and Clinician-Rated Measures of Sleep in Depressed Patients: A Double-Blind, 8-Week Clinical Trial
May 15, 1997
J. Christian Gillin
,
Mark Rapaport
,
Milton K. Erman
, et al
